Overview
Non-syndromic uterovaginal malformation refers to a group of congenital anomalies affecting the development of the uterus and/or vagina that occur in isolation, without the additional features seen in syndromic conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 or other multi-system disorders. These malformations arise from abnormal development of the Müllerian (paramesonephric) ducts during embryogenesis and can include a wide spectrum of anomalies such as uterine agenesis, vaginal agenesis, uterine septum, bicornuate uterus, unicornuate uterus, uterus didelphys, or obstructive vaginal anomalies. The reproductive system is the primary body system affected, though secondary consequences may involve the urinary tract in some cases. Clinically, these malformations may present at puberty with primary amenorrhea (absence of menstruation), cyclic pelvic pain due to obstructed menstrual flow, or may remain undetected until difficulties with sexual intercourse or infertility arise in adulthood. Some patients are diagnosed incidentally during imaging for other reasons. The severity of symptoms depends on the specific type and degree of the malformation. Diagnosis typically involves pelvic ultrasound, MRI, and sometimes hysteroscopy or laparoscopy for definitive characterization. Treatment is tailored to the specific malformation and the patient's symptoms and reproductive goals. Surgical interventions may include vaginoplasty (creation or reconstruction of the vagina), hysteroscopic resection of uterine septa, or other reconstructive procedures. Non-surgical vaginal dilation therapy (such as the Frank method) is often a first-line approach for vaginal agenesis. Assisted reproductive technologies may be considered for patients with fertility challenges. Psychological support is also an important component of care, as these conditions can significantly impact quality of life and emotional well-being.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Non-syndromic uterovaginal malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Non-syndromic uterovaginal malformation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Non-syndromic uterovaginal malformation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Non-syndromic uterovaginal malformation.
Community
No community posts yet. Be the first to share your experience with Non-syndromic uterovaginal malformation.
Start the conversation →Latest news about Non-syndromic uterovaginal malformation
No recent news articles for Non-syndromic uterovaginal malformation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Non-syndromic uterovaginal malformation
What is Non-syndromic uterovaginal malformation?
Non-syndromic uterovaginal malformation refers to a group of congenital anomalies affecting the development of the uterus and/or vagina that occur in isolation, without the additional features seen in syndromic conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 or other multi-system disorders. These malformations arise from abnormal development of the Müllerian (paramesonephric) ducts during embryogenesis and can include a wide spectrum of anomalies such as uterine agenesis, vaginal agenesis, uterine septum, bicornuate uterus, unicornuate uterus, uterus didelphys, or obst